Published in AIDS Weekly, July 8th, 1996
The data described by senior Abbott researcher Akhter Molla is expected to be released during the July 1996 XI International Conference on AIDS in Vancouver, Canada.
Molla said that the combination of ritonavir with the less potent protease inhibitor saquinavir (Invirase, Roche) "holds great promise."
Molla described the studies during a presentation to the International Business Communications (IBC) workshop "HIV Protease Inhibitors," held June 11, 1996 in San Francisco, California.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1996-07-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.